By replacing or making mutated cells inactive, cell and gene therapy can hit life-threatening diseases where it hurts the most in this view, CGT has the potential to emerge as one of the futures biggest catalysts for providing innovative healthcare solutions and improving patient outcomes. Biologics and Biosimilars address the symptoms but not the root cause, leaving a vast opportunity for cell and gene therapy to potentially be integrated into therapeutic strategies to focus on cures instead of symptoms. At the helm of these contemporary solutions are cell and gene therapies (CGTs) that modify gene expression in living cells to treat diseases and is already one of the fastest growing fields in healthcare. This is done by using nucleic acids to replace/deactivate disease-causing gene or introduce a new gene into the cell.